Optiscan Imaging Limited (ASX:OIL) Insider Buys A$23,446.20 in Stock

Optiscan Imaging Limited (ASX:OIL) insider Camile Farah acquired 195,385 shares of Optiscan Imaging stock in a transaction that occurred on Monday, March 17th. The shares were purchased at an average cost of A$0.12 ($0.08) per share, with a total value of A$23,446.20 ($14,746.04).

Optiscan Imaging Price Performance

The firm has a market cap of $129.48 million, a P/E ratio of -21.36 and a beta of 1.20. The company has a debt-to-equity ratio of 1.59, a quick ratio of 5.94 and a current ratio of 8.59.

About Optiscan Imaging

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging.